Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
暂无分享,去创建一个
D. Cameron | D. Dodwell | R. Bell | M. Keane | P. Barrett-Lee | R. Coleman | Caroline Wilson | E. Rathbone | S. Hinsley | H. Marshall | R. Grieve | M. Gil | R. Burkinshaw | D. Ritchie | V. Liversedge | Victoria Liversedge